Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Florida
Jonsson Comprehensive Cancer Center
University of Nebraska
Cancer Research UK
Washington University School of Medicine
Arbeitsgemeinschaft medikamentoese Tumortherapie
Cedars-Sinai Medical Center
CureOne
University of Texas Southwestern Medical Center
Stanford University